Cellcolabs vs Valthos AI Biodefense
Cellcolabs vs Valthos AI Biodefense, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cellcolabs is on 55/100 and Valthos AI Biodefense on 35/100.
Where each one leads
Cellcolabs
- our overall score: 55/100 against 35/100
- agent readiness: 40/100 against 26/100
- domain rating: 36/100 against 30/100
- headcount: 79 against 11
- LinkedIn following: 6,563 against 2,901
Valthos AI Biodefense
- funding raised: $30.0M against $15.5M
At a glance
| Measure | Cellcolabs | Valthos AI Biodefense |
|---|---|---|
| What it is | AI-powered platform for personalized cell therapy development and manufacturing. | Valthos is an applied biological intelligence company. We develop and deploy software and AI methods to outsmart biological evolution and ensure that these tools are deployed to safeguard humanity. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, Defense Tech, HealthTech, AI-Driven Protein Design |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2021 | 2023 |
| Headquarters | Tel Aviv, Israel | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Cellcolabs | Valthos AI Biodefense |
|---|---|---|
| Employees | 79 | 11 |
| Open roles | Not published | 8 |
| Total funding | $15.5M | $30.0M |
| Latest round | Not published | Seed |
| LinkedIn followers | 6,563 | 2,901 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cellcolabs | Valthos AI Biodefense |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 35/100 |
| Search visibility | 2/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (26/100) |
| Domain ratingLink authority, 0-100 | 36/100 | 30/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cellcolabs | Valthos AI Biodefense |
|---|---|---|
| Hosting | Not detected | Vercel |
| CDN | Cloudflare | Vercel |
| Frameworks | Not detected | Next.js, Tailwind CSS |
| Analytics | Google Tag Manager | Not detected |
Cellcolabs vs Valthos AI Biodefense: common questions
Which is better, Cellcolabs or Valthos AI Biodefense?
On our 0-100 score Cellcolabs rates higher (55/100 against 35/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Cellcolabs and Valthos AI Biodefense compare on the numbers?
Cellcolabs leads on our overall score (55/100 against 35/100), agent readiness (40/100 against 26/100), domain rating (36/100 against 30/100), headcount (79 against 11), LinkedIn following (6,563 against 2,901). Valthos AI Biodefense leads on funding raised ($30.0M against $15.5M).
Read the full Cellcolabs review and pricing or the Valthos AI Biodefense review and pricing. You can also browse other Cellcolabs alternatives we track.